Welcure Drugs & Pharmaceuticals Ltd - WELCURE DRUGS Share Price

Sector: Pharmaceuticals | ISIN: INE331C01017

Welcure Drugs & Pharmaceuticals Ltd KEY RATIOS

No Record Found

Welcure Drugs & Pharmaceuticals Ltd Corporate Actions

23 May , 2023

12:00 AM

23 May , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

01 Feb , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

01 Feb , 2023

12:00 AM

24 Nov , 2022

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

01 Oct , 2022

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

01 Oct , 2022

12:00 AM

09 Jul , 2022

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

09 Jul , 2022

12:00 AM

26 May , 2022

12:00 AM

AGM

Announcement date: 26 May , 2022

View Details

26 May , 2022

12:00 AM

BookCloser

View Details

Welcure Drugs & Pharmaceuticals Ltd SHAREHOLDING SNAPSHOT
03 June , 2023 | 01:10 PM

PROMOTER - TOTAL0.00%

Indian: 0.00%

Foreign: 0%

NON-PROMOTER - TOTAL 100.00%

Institutions: 0.01%

Non-Institutions: 99.99%

CUSTODIES - 0.00%

Custodies: 0.00%

See More Details

Invest wise with Expert advice

mobile icon
  • Open Demat with exclusive Advice & Services
  • Get a dedicated Relationship Manager to help you grow your wealth
  • Exclusive advisory on 20+ trading & wealth based investment options
  • One tap Investments, Automated trading & much more
  • Minimum 1 lakh margin required

Welcure Drugs & Pharmaceuticals Ltd News and Update

Image not found
  • 1 day ago |
  • 5:44 PM

According to Aditya Birla Capital Ltd., the preferential issuance would take place at a cost of Rs 165.1 per equity share and is pending approval from shareholders.

Image not found
Image not found
  • IIFL News Service |
  • 29 May, 2023 |
  • 5:39 PM
Image not found
  • IIFL News Service |
  • 23 May, 2023 |
  • 5:30 PM
ad IconAd Image

Welcure Drugs & Pharmaceuticals Ltd FINANCIALS

No Data Available To Display Chart

Welcure Drugs & Pharmaceuticals Ltd PEER COMPARISON

Figures of Market Capital(Mar Cap), Quaterly Net Profit(NP Qtr) and Quaterly Sales(Sales Qtr) are in ₹ Cr.View All Peer Comparison

MORE ABOUT Welcure Drugs & Pharmaceuticals Ltd

  • Gagan Juneja
  • Non-Exec. & Independent Dir.
  • Mohd. Shahbaz Alam
  • Independent Director
  • Sitaben S Patel
  • Additional Director
  • Rajeev Mehra
  • Additional Director

Summary

Summary Info Not Found


Reports by Welcure Drugs & Pharmaceuticals Ltd


Reports by Welcure Drugs & Pharmaceuticals Ltd